STOFF 2016
December 8 - 11, 2016 Cary, North Carolina Program Brochure (PDF)
Key Meeting Topics
Phase I Clinical Trials: Hypothesis Testing Pharmacogenomics Immune Checkpoint Inhibition in Advanced Cancer Oncology Drug Development: A Regulatory Perspective
Presentation Summaries

New Drug Development in 2016: Progress, Challenges, and Prices
Thomas G. Roberts, Jr., MD, MSoc Sci
Summary (PDF)

Receptor-Associated Kinase Inhibitor / Intracellular Resistance Pathways
Jeffrey Engelman, MD, PhD
Summary (PDF)
Acknowledgments
Summaries were created from the proceedings of the Society for Translational Oncology Fellows’ Forum held on December 8-11, 2016 in Cary, NC.
The Society for Translational Oncology gratefully acknowledges support of this activity from: